LANGER DENNIS
SEC insider (Form 3/4/5 filer). CIK 0001274225. Director at Quoin Pharmaceuticals Ltd. (QNRX). 6 reported Form 4/5 transactions since Sep 2024; latest on Aug 27, 2026. Located in ASHBURN, VA.
Companies LANGER DENNIS has filed insider reports for
- Quoin Pharmaceuticals Ltd. (QNRX): Director
LANGER DENNIS
CIK: 0001274225
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Quoin Pharmaceuticals Ltd.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Aug 27, 2026QNRX
Quoin Pharmaceuticals, Ltd.
AwardDirect34.5K shares at avg. $5.15$178K - Feb 4, 2026QNRX
Quoin Pharmaceuticals, Ltd.
AwardDirectShare Option (Right to Buy)
21.7K shares- - Oct 14, 2025QNRX
Quoin Pharmaceuticals, Ltd.
PurchaseDirect15.2K shares at avg. $8.49$129K - Aug 21, 2025QNRX
Quoin Pharmaceuticals, Ltd.
AwardDirectShare Option (Right to Buy)
13.7K shares- - May 29, 2025QNRX
Quoin Pharmaceuticals, Ltd.
AwardDirectShare Option (Right to Buy)
7.8K shares- - Dec 9, 2024QNRX
Quoin Pharmaceuticals, Ltd.
AwardDirectShare Option (Right to Buy)
50.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 27, 2026 | QNRX Quoin Pharmaceuticals, Ltd. | Award | 34,534 | $5.15 | $177,850 | Direct |
| Feb 4, 2026 | QNRX Quoin Pharmaceuticals, Ltd. | Award Share Option (Right to Buy) | 21,709 | - | - | Direct |
| Oct 14, 2025 | QNRX Quoin Pharmaceuticals, Ltd. | Purchase | 15,152 | $8.49 | $128,640 | Direct |
| Aug 21, 2025 | QNRX Quoin Pharmaceuticals, Ltd. | Award Share Option (Right to Buy) | 13,682 | - | - | Direct |
| May 29, 2025 | QNRX Quoin Pharmaceuticals, Ltd. | Award Share Option (Right to Buy) | 7,760 | - | - | Direct |
| Dec 9, 2024 | QNRX Quoin Pharmaceuticals, Ltd. | Award Share Option (Right to Buy) | 50,714 | - | - | Direct |
1-6 of 6 transactions